PhRMA Adopts Outcomes Research Policy; Set For Cost-Effectiveness Debate
Executive Summary
Government-supported health outcomes research must recognize the benefits of multiple treatment options, the Pharmaceutical Research & Manufacturers of America's principles on outcomes research say
You may also be interested in...
PhRMA’s Evidence-Based Medicine Principles Emphasize Individual Decisions
The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians
PhRMA’s Evidence-Based Medicine Principles Emphasize Individual Decisions
The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians
PhRMA Must Tackle Cost-Effectiveness “Dilemma,” J&J’s Weldon Says
The Pharmaceutical Research & Manufacturers of America is considering the development of principles on evidence-based medicine to help it engage more directly in the debate over the cost-effectiveness of medicines